How Should You Use HCG for PCT After Steroids? (TRT Q&As)
Timeline
A 51-year-old man asks how to use HCG as part of post-cycle therapy. Dr. O’Connor explains that recovery after steroids varies considerably and discusses HCG as a way to stimulate the testicles during the transition, while emphasizing that there is no single proven PCT protocol that guarantees restoration of the natural hormonal axis.
A 39-year-old man reports that his hemoglobin increased from 17 before TRT to 19.5 while taking 180 mg of testosterone per week. Dr. O’Connor discusses evaluating factors such as sleep apnea, smoking, genetics, hydration, and cardiovascular risk, while using CBC and iron studies to guide minimal phlebotomy without unnecessarily depleting ferritin.
Dr. O’Connor explains that these symptoms could represent an uncommon medication side effect or an unrelated illness and recommends discussing them with the prescribing physician before abandoning an important cholesterol-lowering therapy. Because the member has significant arterial plaque and cardiovascular risk, he stresses finding a tolerable lipid-lowering strategy rather than simply stopping treatment.
A 29-year-old man reports that his blood pressure increased from roughly 110–115 before TRT to around 130–135 during the day after starting testosterone. Dr. O’Connor discusses lowering testosterone exposure, staying lean, limiting sodium, exercising, maintaining appropriate hydration, and monitoring blood pressure, while explaining that some men may still require medication because of genetics and other risk factors.
Video Summary
This mailbag discussion focuses on questions about mood variability reported during testosterone therapy. It explains that mood changes can be influenced by hormones, sleep, stress, and life circumstances rather than testosterone alone. Emotional shifts are framed as multifactorial signals requiring perspective.
A central portion discusses how labs and symptom trends should be reviewed together when mood concerns arise. The episode emphasizes avoiding immediate attribution to dosing without broader assessment. Contextual evaluation is highlighted to guide appropriate response.
The closing segment reinforces testosterone therapy as one component of mental and emotional health. Ongoing monitoring, expectation alignment, and proportional decision-making are emphasized. Hormone therapy is positioned as supportive rather than determinative of mood.
Drug Callouts
Condition Callouts
Key Takeaways
- Mood changes during therapy often have multiple causes.
- Hormones are only one influence on mood.
- Sleep and stress strongly affect emotional state.
- Labs and symptoms should be reviewed together.
- Context prevents unnecessary therapy changes.